Highlighting ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) As A Catalyst Play This Quarter

In Donald Trump’s latest press conference, the President-elect took a swipe at the healthcare and pharmaceutical space, suggesting that drug companies are getting away with murder, and hinting at some sort of legislation to limit said companies’ ability to charge the (admittedly exorbitant) prices they currently list. True to form, the biotech sector has taken a hit on the conference, and a…